Skip to main content
Menu
Home
About us
Team
Companies
Stories
ESG
News
Keensight Connect
Contact
Close Search
Press Release
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US
By
WeAreBlow
October 25, 2022
No Comments
Download
Previous Post
Keensight Capital has reinforced its stake in Unither
Next Post
Keensight Capital wins Best Corporate Sustainability Strategy at the Private Equity Wire ESG AAA European Awards 2022
Close Menu
Home
About us
Team
Companies
Stories
ESG
News
Keensight Connect
Contact